Maxx Orthopedics Announces First International Surgeries of its Freedom® PCK Revision System

My Subscriptions

Payment Confirmation

Transaction Failed

Your transaction failed, please try again or contact site support.

Maxx Orthopedics, Inc., announced today that the Freedom® PCK Revision System at the AAHKS 2017 Annual Meeting in Dallas this week.  The company made available the Freedom® PCK Revision System globally, with the first surgeries performed in India and several Gulf countries, including Oman and the United Arab Emirates.

The Freedom PCK Revision System combines the Freedom Stemmed Tibial components with the patent-pending PCK femoral components and constrained liners, to create one of the most bone conserving, versatile revision knee systems available on the market. Designed in collaboration with a global surgeon team, the PCK Revision System has been available for use in the United States since early 2016.

The company notes that the first case was performed by Dr. Hemant Wakankar at Max Elite Hospital in Chandigarh in India.  Dr. Wakankar said, “The design of the PCK is exceptional and its features are particularly well suited for my patients. I believe they will have better range of motion even after a revision surgery because of this unique progressive constraint system. “It gives me the opportunity to provide better results for my patients,” concluded Dr. Wakankar.

Dr. Carl Becker, a leading surgeon at Penn Medicine’s Lancaster General Hospital in Lancaster, PA, is one of the key design surgeons for the PCK, and has traveled internationally for peer-to-peer discussions on the system.  “I have had the pleasure of working with Maxx’s global team to help design a revision implant which delivers significant benefits for the surgeon and patient. Furthermore, our instruments make the surgery intuitive, and I am excited that this solution is now being offered to my colleagues all over the world.”

“Our team is thrilled by the early clinical success of this system and we are excited to continue our global rollout. The PCK is a revision knee designed with the needs of today’s patients AND today’s economic realities in mind. It’s smart innovation, and this has become a hallmark for our company,” said Ashesh Shah, CEO of Maxx Orthopedics.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.